Literature DB >> 6791592

Steroid-responsive and nephrotic syndrome and allergy: clinical studies.

S R Meadow, J K Sarsfield.   

Abstract

Eighty-four children with steroid-responsive nephrotic syndrome who had been shown to have, or were believed to have, minimal change histology were investigated to study the relationship between steroid-responsive nephrotic syndrome and allergy. They were found to have a greater incidence of the standard atopic disorders--asthma, eczema, recurrent urticaria, and hay fever. Their 1st-degree relatives had an increased incidence of these atopic disorders too. A nasal discharge was a frequent precursor or an accompaniment of nephrotic syndrome, but an overt atrophic disorder at the same time was rare. Such disorders, related to relapse, occurred in only 5 children; in none was it a consistent or recurrent happening at the time of each relapse. No example of pollen hypersensitivity nephrotic syndrome was found, and no particular allergen could be identified with certainty as responsible for a child's nephrotic syndrome. No association was found between the time of relapse and the season of the year, or the season in which the child was born. Children with nephrotic syndrome had a greater incidence of positive skin tests to common antigens, the comparative frequency of positive reactions to different antigens being similar to that found in children with asthma, although the total frequency was about half that of children with asthma. Despite the increased incidence of clinical features of atopy, measures to reduce the frequency of relapse of nephrotic syndrome by allergen avoidance, the use of sodium cromoglycate, and the use of a new oral antiallergic drug were unsuccessful.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6791592      PMCID: PMC1627348          DOI: 10.1136/adc.56.7.509

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  18 in total

1.  Incidence of allergy in a pediatric population. Pilot survey of 2,169 children.

Authors:  H G RAPAPORT; S J APPEL; V L SZANTON
Journal:  Ann Allergy       Date:  1960-01

2.  Predisposing factors and the development of reaginic allergy in infancy.

Authors:  J F Soothill; C R Stokes; M W Turner; A P Norman; B Taylor
Journal:  Clin Allergy       Date:  1976-07

3.  Disodium cromoglycate in gastrointestinal protein intolerance.

Authors:  S Freier; H Berger
Journal:  Lancet       Date:  1973-04-28       Impact factor: 79.321

4.  Transient IgA deficiency and pathogenesis of infantile atopy.

Authors:  B Taylor; A P Norman; H A Orgel; C R Stokes; M W Turner; J F Soothill
Journal:  Lancet       Date:  1973-07-21       Impact factor: 79.321

5.  Nephrotic syndrome associated with inhaled allergens.

Authors:  H J Wittig; A S Goldman
Journal:  Lancet       Date:  1970-03-14       Impact factor: 79.321

6.  The use of cromolyn sodium in the treatment of asthma in children.

Authors:  C W Bierman
Journal:  Pediatrics       Date:  1975-05       Impact factor: 7.124

7.  The absorption, excretion and metabolism of disodium (14C)cromoglycate in man.

Authors:  S R Walker; A J Richards; J W Paterson
Journal:  Biochem J       Date:  1971-11       Impact factor: 3.857

8.  Seasonal nephrotic syndrome. Description and immunological findings.

Authors:  W G Reeves; J S Cameron; S G Johansson; C S Ogg; D K Peters; R O Weller
Journal:  Clin Allergy       Date:  1975-06

9.  HLA antigens and atopic features in steroid-responsive nephrotic syndrome of childhood.

Authors:  P D Thomson; C R Stokes; T M Barratt; M W Turner; J F Soothill
Journal:  Lancet       Date:  1976-10-09       Impact factor: 79.321

10.  Severe steroid-responsive nephrosis associated with hypersensitivity.

Authors:  D H Sandberg; C W Bernstein; R M McIntosh; R Carr; J Strauss
Journal:  Lancet       Date:  1977-02-19       Impact factor: 79.321

View more
  20 in total

1.  Simvastatin treatment in nephrotic syndrome associated with a bee sting.

Authors:  T Révai; G Harmos
Journal:  J R Soc Med       Date:  1999-01       Impact factor: 5.344

2.  Risk of idiopathic nephrotic syndrome among children with asthma: a nationwide, population-based cohort study.

Authors:  Chang-Ching Wei; Cheng-Li Lin; Te-Chun Shen; Yu-Fen Li
Journal:  Pediatr Res       Date:  2015-04-30       Impact factor: 3.756

3.  Apolipoprotein AII levels are associated with the UP/UCr levels in idiopathic steroid-sensitive nephrotic syndrome.

Authors:  Takahiro Kanai; Takanori Yamagata; Takane Ito; Jun Odaka; Takashi Saito; Jun Aoyagi; Mariko Y Momoi
Journal:  Clin Exp Nephrol       Date:  2014-03-15       Impact factor: 2.801

4.  Recent advances in minimal change nephrotic syndrome.

Authors:  K P Mehta; U Ali
Journal:  Indian J Pediatr       Date:  1985 Nov-Dec       Impact factor: 1.967

5.  Th2 cells predominate in idiopathic steroid-sensitive nephrotic syndrome.

Authors:  Takahiro Kanai; Hirohiko Shiraishi; Takanori Yamagata; Takane Ito; Jun Odaka; Takashi Saito; Jun Aoyagi; Mariko Y Momoi
Journal:  Clin Exp Nephrol       Date:  2010-08-05       Impact factor: 2.801

6.  Steroid-responsive nephrotic syndrome and allergy.

Authors:  K Schärer; U Wahn; D E Müller-Wiefel; W Rebien
Journal:  Arch Dis Child       Date:  1982-05       Impact factor: 3.791

Review 7.  Minimal change nephropathy and focal segmental glomerulosclerosis.

Authors:  Peter W Mathieson
Journal:  Semin Immunopathol       Date:  2007-10-23       Impact factor: 9.623

8.  Steroid-responsive nephrotic syndrome and allergy: immunological studies.

Authors:  S R Meadow; J K Sarsfield; D G Scott; S M Rajah
Journal:  Arch Dis Child       Date:  1981-07       Impact factor: 3.791

9.  Increased risk of idiopathic nephrotic syndrome in children with atopic dermatitis.

Authors:  Chang-Ching Wei; Jeng-Dau Tsai; Cheng-Li Lin; Te-Chun Shen; Tsai-Chung Li; Chi-Jung Chung
Journal:  Pediatr Nephrol       Date:  2014-07-18       Impact factor: 3.714

10.  Cyclosporin A in steroid-sensitive nephrotic syndrome with frequent relapses.

Authors:  M K Chan; I K Cheng
Journal:  Postgrad Med J       Date:  1987-09       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.